A comparison of the ADC and T2 mapping in an assessment of blood-clot lysability

NMR in Biomedicine

Volumn 23, Issue 1, 2010, Pages 34-40

  Vidmar, Jernej ^a   Blinc, Aleš ^b   Serša, Igor ^a  

^a JO EF STEFAN INSTITUTE   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

ADC mapping; MR microscopy; T2 mapping; Thrombolysis

Indexed keywords

ADC MAPPING; APPARENT DIFFUSION COEFFICIENT; BLOOD CLOTS; DIFFUSION PROPERTIES; HIGHLY SENSITIVE; IN-VIVO; MR MICROSCOPY; STRUCTURAL CHARACTERISTICS; THROMBOLYSIS; TISSUE PLASMINOGEN ACTIVATOR;

BLOOD; DISSOLUTION; MAPPING; SURFACE DIFFUSION;

MULTICARRIER MODULATION;

ALTEPLASE; FIBRIN; TISSUE PLASMINOGEN ACTIVATOR;

ACCURACY; APPARENT DIFFUSION COEFFICIENT; ARTICLE; BLOOD CLOT; BLOOD CLOT LYSIS; BLOOD CLOT RETRACTION; BLOOD SAMPLING; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DISSOLUTION; EXPERIMENTAL MODEL; HUMAN; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PLASMA; PRIORITY JOURNAL; FIBRINOLYTIC THERAPY; METABOLISM; METHODOLOGY; PATHOLOGY; THROMBOSIS; TREATMENT OUTCOME;

FIBRIN; HUMANS; MAGNETIC RESONANCE IMAGING; THROMBOLYTIC THERAPY; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 75149142228     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1422     Document Type: Article

References (33)

1. Goldhaber SZ, Haire WD, Feldstein ML, Miller M, Toltzis R, Smith JL, Taveira da Silva AM, Come PC, Lee RT, Parker JA, Mogtader A, McDonough TJ, Braunwald E. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet 1993; 341: 507-511.
2. Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N. Engl. J. Med. 2002; 347: 1143-1150.
3. Ouriel K, Castaneda F, McNamara T, Swischuk J, Tepe G, Smith JJ, Clark J, Duda S. Reteplase monotherapy and reteplase/abciximab combination therapy in peripheral arterial occlusive disease: results from the RELAX trial. J. Vasc. Interv. Radiol. 2004; 15: 229-238.
4. Ouriel K, Veith FJ, Sasahara AA. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators. N. Engl. J. Med. 1998; 338: 1105-1111.
5. Atlas SW, DuBois P, Singer MB, Lu D. Diffusion measurements in intracranial hematomas: implications for MR imaging of acute stroke. AJNR Am. J. Neuroradiol. 2000; 21: 1190-1194.
6. Maldjian JA, Listerud J, Moonis G, Siddiqi F. Computing diffusion rates in T2-dark hematomas and areas of low T2 signal. AJNR Am. J. Neuroradiol. 2001; 22: 112-118.
7. Kang BK, Na DG, Ryoo JW, Byun HS, Roh HG, Pyeun YS. Diffusionweighted MR imaging of intracerebral hemorrhage. Korean J. Radiol. 2001; 2: 183-191.
8. Sersa I, Vidmar J, Grobelnik B, Mikac U, Tratar G, Blinc A. Modelling the effect of laminar axially directed blood flow on the dissolution of non-occlusive blood clots. Phys. Med. Biol. 2007; 52: 2969-2985.
9. Sakharov DV, Rijken DC. The effect of flow on lysis of plasma clots in a plasma environment. Thromb. Haemost. 2000; 83: 469-474.
10. Blinc A, Francis CW. Transport processes in fibrinolysis and fibrinolytic therapy. Thromb. Haemost. 1996; 76: 481-491.
11. Kozak M, Mikac U, Blinc A, Sersa I. Lysability of arterial thrombi assessed by magnetic resonance imaging. Vasa 2005; 34: 262-265.
12. Tratar G, Blinc A, Podbregar M, Kralj E, Balazic J, Sabovic M, Sersa I. Characterization of pulmonary emboli ex vivo by magnetic resonance imaging and ultrasound. Thromb. Res. 2007; 120: 763-771.
13. Chu K, Kang DW, Yoon BW, Roh JK. Diffusion-weighted magnetic resonance in cerebral venous thrombosis. Arch. Neurol. 2001; 58: 1569-1576.
14. Tanaka K, Onji T, Okamoto K, Matsusaka T, Taniguchi H, Shibata N. Reorganization of contractile elements in the platelet during clot retraction. J. Ultrastruct. Res. 1984; 89: 98-109.
15. Morgenstern E, Korell U, Richter J. Platelets and fibrin strands during clot retraction. Thromb. Res. 1984; 33: 617-623.
16. Furie B, Furie BC. Mechanisms of thrombus formation. N. Engl. J. Med. 2008; 359: 938-949.
17. Blackmore CC, Francis CW, Bryant RG, Brenner B, Marder VJ. Magnetic resonance imaging of blood and clots in vitro. Invest. Radiol. 1990; 25: 1316-1324.
18. Francis CW, Totterman S. Magnetic resonance imaging of deep vein thrombi correlates with response to thrombolytic therapy. Thromb. Haemost. 1995; 73: 386-391.
19. Malinovsky NN, Gruzdev AK, Beskaeva LM, Salnikov DV, Nikerov KY, Abramov AS, Fineshin IN. The efficacy of alteplase in pulmonary embolism treatment. Khirurgiia (Mosk) 2008; 7: 4-7.
20. Tratar G, Blinc A, Strukelj M, Mikac U, Sersa I. Turbulent axially directed flow of plasma containing rt-PA promotes thrombolysis of nonocclusive whole blood clots in vitro. Thromb. Haemost. 2004; 91: 487-496.
21. Carr HY, Purcell EM. Effects of diffusion on free precession in nuclear magnetic resonance experiments. Phys. Rev. 1954; 94: 630-638.
22. Stejskal EO, Tanner JE. Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient. J. Chem. Phys. 1965; 42: 288-292.
23. Blinc A, Lahajnar G, Blinc R, Zidansek A, Sepe A. Proton NMR study of the state of water in fibrin gels, plasma, and blood clots. Magn. Reson. Med. 1990; 14: 105-122.
24. Hazlewood CF, Rorschach HE, Lin C. Diffusion of water in tissues and MRI. Magn. Reson. Med. 1991; 19: 214-216.
25. Hayman LA, Taber KH, Ford JJ, Saleem A, Gurgun M, Mohamed S, Bryan RN. Effect of clot formation and retraction on spin-echo MR images of blood: an in vitro study. AJNR Am. J. Neuroradiol. 1989; 10: 1155-1158.
26. Assouline E, Benziane K, Reizine D, Guichard JP, Pico F, Merland JJ, Bousser MG, Chabriat H. Intra-arterial thrombus visualized on T2* gradient echo imaging in acute ischemic stroke. Cerebrovasc. Dis. 2005; 20: 6-11.
27. Blinc A, Keber D, Lahajnar G, Zupancic I, Zorec-Karlovsek M, Demsar F. Magnetic resonance imaging of retracted and non-retracted blood clots during fibrinolysis in vitro. Haemostasis 1992; 22: 195-201.
28. Sabovic M, Lijnen HR, Keber D, Collen D. Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators. Thromb. Haemost. 1989; 62: 1083-1087.
29. Sabovic M, Blinc A. Biochemical and biophysical conditions for blood clot lysis. Pflugers. Arch. 2000; 440: R134-136.
30. Loebinger MR, Bradley JC. Thrombolysis in pulmonary embolism: are we under-using it? QJM-int. J. Med. 2004; 97: 361-364.
31. Rosenblum JK, Cynamon J. Mechanical and enzymatic thrombolysis of acute pulmonary embolus: review of the literature and cases from our institution. Vascular 2008; 16: 213-218.
32. Sakharov DV, Rijken DC. Superficial accumulation of plasminogen during plasma clot lysis. Circulation 1995; 92: 1883-1890.
33. Sabovic M, Lijnen HR, Keber D, Collen D. Correlation between progressive adsorption of plasminogen to blood clots and their sensitivity to lysis. Thromb. Haemost. 1990; 64: 450-454.